The Europe digital genome market is expected to reach US$ 5,994.09 million by 2027 from US$ 3,250.04 million in 2019. The market is estimated to grow at a CAGR of 8.1% during 2020-2027. The digital genome market is growing primarily due to the increasing prevalence of chronic diseases and growing funding for genomics in the Europe region. Factors such as security and confidentiality issue damage the growth of the market. Additionally, increasing technological advancement in digital genome field and increasing demand for personalized medicines are likely to fuel the growth of the digital genome market during the forecast period.
The digital genome is advanced progress in understanding animal and plant genetic material is being driven through advancements in DNA sequencing technology.It helps in gathering information related to chronic diseases and utilized to get an understanding of genetic disorders.
A digital genome facilitates instant access to trait sequences to resolve unending custom queries.
Increasing technological advancements is expected to drive the growth of the digital genome market.For instance, in December 2012, 100,000 Genomes Project was announced, it is a UK Government project that is sequencing around 100,000 genomes from around 85,000 National Health Service patients affected by rare diseases, some common types of cancer, and infectious diseases.
This project is mainly funded by National Institute for Health Research and NHS England. Also, Wellcome Trust, Cancer Research UK and the Medical Research Council funded the research and infrastructure in the programme.
Furthermore, artificial intelligence and machine learning methods are currently being used to overcome various problems faced by genomics such as annotating genomic sequence elements and identifying splice sites, promoters, enhancers, and positioned nucleosomes. For instance, Sapientia-a clinical genomics analysis platform from Congenica-uses algorithms to annotate and prioritize variants from whole exome sequencing to assist in the diagnosis of rare diseases.
Such strategic initiatives are likely to offer growth opportunities for the market players to attain a significant position and grow in the digital genome market.
The outbreak of COVID-19 has led to thorough research on COVID-19 in the Europe.The European Commission and the European Bioinformatics Institute (EBI) have launched the European COVID-19 Data Portal.
This brings together relevant datasets for sharing and analysis in an effort to accelerate COVID-19 research.Furthermore, ELIXIR provides a range of services that to the genomic researchers for studying the SARS-CoV-2 coronavirus and the COVID-19 disease.
Thus, growing efforts for COVID19 research is expected to enhance the market growth of digital genome during the forecast period.
In 2019, the sequencing and analyzer instruments segment accounted for the largest share of the market.Growth in this segment can be attributed to the increasing adoption of analyzing instruments for sequencing by pharmaceutical and biopharmaceutical companies in advanced economies.
Moreover, companies are focusing on supplying superior quality instruments to research centers and pharmaceutical companies that are involved in developing therapies for genetic diseases, which will offer lucrative opportunities during the forecast period.
A few of the significant secondary sources associated with the Europe Digital Genome market report World Health Organization (WHO), European Chronic Disease Alliance (ECDA), and others.
Our reports have been used by over 10K customers, including:
The Asia Pacific digital genome market is expected to reach US$ 4,118.86 million by 2027 from US$ 2,077.27 million in 2019. The market is estimated to grow at a CAGR of 9.1% during 2020-2027. The digital genome market is growing primarily due to the increasing prevalence of chronic diseases and growing funding for genomics in the Asia Pacific...
The North America digital genome market is expected to reach US$ 9,594.71 million by 2027 from US$ 4,999.94 million in 2019. The market is estimated to grow at a CAGR of 8.7% during 2020-2027. The digital genome market is growing primarily due to the increasing prevalence of chronic diseases and growing funding for genomics in the North America...
2024 Global Nucleic Acid Testing/NAT Market: Supplier Shares by Country, Emerging technologies and Strategic Profiles of Leading Suppliers This 180-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA...
178 pages •
By Global Industry Analysts
• Sep 2020
Global RNA Analysis/Transcriptomics Market to Reach $8.7 Billion by 2027 Amid the COVID-19 crisis, the global market for RNA Analysis/Transcriptomics estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$8.7 Billion by 2027, growing at a CAGR of 13.1% over the analysis period 2020-2027. Microarray,...
148 pages •
By Global Industry Analysts
• Jul 2020
Global Microbiome Sequencing Services Market to Reach $2.9 Billion by 2027 Amid the COVID-19 crisis, the global market for Microbiome Sequencing Services estimated at US$931.8 Million in the year 2020, is projected to reach a revised size of US$2.9 Billion by 2027, growing at a CAGR of 17.8% over the analysis period 2020-2027. Synthesis,...
Nutrigenomics Market Research Report by Product (Reagents & Kits and Services), by Application (Cancer, Cardiovascular Diseases, and Obesity) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Nutrigenomics Market is expected to grow from USD 325.31 Million in 2019 to USD 811.63 Million by the end...
The nucleic acid isolation and purification market is projected to grow at a CAGR of 8.9% during the forecast period (2020–2025). The global nucleic acid isolation and purification market is projected to reach USD 4.8 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 8.9% during the forecast period. The major factors driving the...
The North America neurological biomarkers market is expected to reach US$ 2,618.68 Mn in 2027 from US$ 7,056.76 Mn in 2019. The market is estimated to grow with a CAGR of 13.4% from 2020-2027. Factors such as growing prevalence of neurological disorders and increasing focus toward research in neurological biomarker are expected to fuel...
The global liquid biopsy market is expected to reach nearly US$ 8.2 Billion by 2027. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. Liquid biopsy aids in planning the required treatment and also check for treatment effectiveness as well as...
154 pages •
By Global Industry Analysts
• Jul 2020
Global Genotyping Market to Reach $46.4 Billion by 2027 Amid the COVID-19 crisis, the global market for Genotyping estimated at US$13.9 Billion in the year 2020, is projected to reach a revised size of US$46.4 Billion by 2027, growing at a CAGR of 18.7% over the analysis period 2020-2027. Polymerase Chain Reaction (PCR), one of the...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.